baclofen has been researched along with Dyskinesia, Drug-Induced in 35 studies
Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
| Excerpt | Relevance | Reference |
|---|---|---|
| " I report a patient who developed the syndrome during treatment for schizophrenia with the antipsychotic agent molindone hydrochloride." | 7.68 | Neuroleptic-induced "painful legs and moving toes" syndrome: successful treatment with clonazepam and baclofen. ( Sandyk, R, 1990) |
| " I report a patient who developed the syndrome during treatment for schizophrenia with the antipsychotic agent molindone hydrochloride." | 3.68 | Neuroleptic-induced "painful legs and moving toes" syndrome: successful treatment with clonazepam and baclofen. ( Sandyk, R, 1990) |
| "One patient developed withdrawal symptoms after baclofen was stopped, and the other developed a manic attach while receiving the drug." | 2.37 | Baclofen-induced psychosis: two cases and a review. ( Iskandar, HL; Yassa, RY, 1988) |
| " The trouble occurs or is worsened when neuroleptics are withdrawn and is reduced when dosage is increased; it responds to the theoretical model of denervation supersensitivity." | 2.36 | [Tardive dyskinesia induced by neuroleptics. A review of the literature]. ( Cottereau, MJ; Deniker, P; Diepart, E, 1979) |
| "Baclofen and oxazepam were prescribed secondary to right-sided hemiparesis contractures." | 1.34 | Potential aripiprazole-mediated extrapyramidal symptoms in an adult with developmental disabilities. ( Brahm, NC; Brown, RC; McElwain, DL, 2007) |
| "Treatment with baclofen (4 mg/kg) did not modify spontaneous VCM." | 1.33 | Effects of baclofen on reserpine-induced vacuous chewing movements in mice. ( Abílio, VC; Castro, JP; Frussa-Filho, R; Fukushiro, DF; Medrano, WA; Ribeiro, Rde A; Silva, RH, 2006) |
| "When selegiline was stopped after 9 years of treatment, abnormal involuntary movements improved to pretreatment level and psychiatric behaviour returned to normal." | 1.32 | Adverse effects of dopamine potentiation by long-term treatment with selegiline. ( Hollán, S; Magyar, K; Vécsei, L, 2004) |
| "Baclofen was also useful in one monkey against a more dystonic form of dyskinesia." | 1.29 | Effect of nondopaminergic drugs on L-dopa-induced dyskinesias in MPTP-treated monkeys. ( Bédard, PJ; Gomez-Mancilla, B, 1993) |
| "Baclofen (Lioresal) is a derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA)." | 1.29 | Baclofen-induced dyskinesia. ( Blumenthal, FS; Ryan, DM, 1993) |
| "Tardive dystonia is an uncommon, disabling side effect of antipsychotic medication that is generally believed to be resistant to treatment." | 1.28 | Tardive dystonia: four case histories. ( Korn, ML; Simpson, GM; Yadalam, KG, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (68.57) | 18.7374 |
| 1990's | 5 (14.29) | 18.2507 |
| 2000's | 4 (11.43) | 29.6817 |
| 2010's | 2 (5.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alabed, S | 1 |
| Latifeh, Y | 1 |
| Mohammad, HA | 1 |
| Bergman, H | 1 |
| Niehaus, MT | 1 |
| Elliott, NC | 1 |
| Katz, KD | 1 |
| Hollán, S | 1 |
| Vécsei, L | 1 |
| Magyar, K | 1 |
| Peixoto, MF | 1 |
| Araujo, NP | 1 |
| Silva, RH | 2 |
| Castro, JP | 2 |
| Fukushiro, DF | 2 |
| Faria, RR | 1 |
| Zanier-Gomes, PH | 1 |
| Medrano, WA | 2 |
| Frussa-Filho, R | 2 |
| Abílio, VC | 2 |
| Ribeiro, Rde A | 1 |
| Brahm, NC | 1 |
| McElwain, DL | 1 |
| Brown, RC | 1 |
| Liebman, J | 1 |
| Neale, R | 1 |
| Stewart, RM | 1 |
| Rollins, J | 1 |
| Beckham, B | 1 |
| Roffman, M | 2 |
| Tegeler, J | 1 |
| Wöller, W | 1 |
| Andrade, LA | 1 |
| Bertolucci, PH | 1 |
| Pereira, JS | 1 |
| Marsden, CD | 1 |
| Sheehy, MP | 1 |
| Wolf, ME | 2 |
| Keener, S | 1 |
| Mathis, P | 1 |
| Mosnaim, AD | 2 |
| Nair, NP | 2 |
| Lal, S | 1 |
| Schwartz, G | 2 |
| Thavundayil, JX | 1 |
| Almy, G | 1 |
| Toll, M | 1 |
| Rastogi, SK | 1 |
| Rastogi, RB | 1 |
| Lapierre, YD | 1 |
| Singhal, RL | 1 |
| Häggström, JE | 1 |
| Feder, R | 1 |
| Moore, DC | 2 |
| Gomez-Mancilla, B | 1 |
| Bédard, PJ | 1 |
| Ryan, DM | 1 |
| Blumenthal, FS | 1 |
| Dressler, D | 1 |
| Yassa, R | 2 |
| Ruiz-Navarro, J | 1 |
| Diepart, E | 1 |
| Cottereau, MJ | 1 |
| Deniker, P | 1 |
| Campanini, T | 1 |
| Catalano, A | 1 |
| De Risio, C | 1 |
| Forino, V | 1 |
| Simpson, GM | 2 |
| Lee, JH | 1 |
| Shrivastava, RK | 1 |
| Branchey, MH | 1 |
| Lees, AJ | 1 |
| Shaw, KM | 1 |
| Stern, GM | 1 |
| Gerlach, J | 2 |
| Rye, T | 1 |
| Kristjansen, P | 1 |
| Amsterdam, J | 1 |
| Mendels, J | 1 |
| Yadalam, KG | 1 |
| Korn, ML | 1 |
| Sandyk, R | 2 |
| Nair, V | 1 |
| Dimitry, R | 1 |
| Yassa, RY | 1 |
| Iskandar, HL | 1 |
| Glazer, WM | 1 |
| Bowers, MB | 1 |
| Bunney, BS | 1 |
4 reviews available for baclofen and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Gamma-aminobutyric acid agonists for antipsychotic-induced tardive dyskinesia.
Topics: Antipsychotic Agents; Baclofen; Dyskinesia, Drug-Induced; GABA Agonists; gamma-Aminobutyric Acid; Hu | 2018 |
[Tardive dyskinesia: I. Physiopathology and treatment].
Topics: Animals; Antipsychotic Agents; Baclofen; Binding Sites; Dopamine; Dyskinesia, Drug-Induced; Humans; | 1984 |
[Tardive dyskinesia induced by neuroleptics. A review of the literature].
Topics: Adolescent; Adult; Age Factors; Aged; Antipsychotic Agents; Athetosis; Baclofen; Child; Chorea; Diag | 1979 |
Baclofen-induced psychosis: two cases and a review.
Topics: Acute Disease; Adult; Aged; Baclofen; Bipolar Disorder; Dyskinesia, Drug-Induced; Female; Humans; Ma | 1988 |
7 trials available for baclofen and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Baclofen in tardive dyskinesia patients maintained on neuroleptics.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Baclofen; Clinical Trials as Topic; Double-Blind Meth | 1982 |
GABA and movement disorders.
Topics: Anticonvulsants; Baclofen; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Induced; | 1981 |
Baclofen in the treatment of tardive dyskinesia.
Topics: Adult; Aminobutyrates; Antipsychotic Agents; Baclofen; Clinical Trials as Topic; Double-Blind Method | 1978 |
Baclofen in the treatment of tardive dyskinesia and schizophrenia.
Topics: Adult; Aminobutyrates; Baclofen; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Female; Humans; | 1978 |
Baclofen in Parkinson's disease.
Topics: Aged; Aminobutyrates; Baclofen; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Indu | 1978 |
Effect of baclofen on tardive dyskinesia.
Topics: Aged; Aminobutyrates; Baclofen; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Indu | 1978 |
The treatment of tardive dyskinesia with baclofen.
Topics: Adolescent; Adult; Aged; Baclofen; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-I | 1985 |
24 other studies available for baclofen and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Baclofen Toxicity Causing Acute, Reversible Dyskinesia.
Topics: Aged, 80 and over; Back Pain; Baclofen; Coronary Artery Disease; Diabetes Mellitus; Drug Interaction | 2016 |
Adverse effects of dopamine potentiation by long-term treatment with selegiline.
Topics: Adolescent; Adult; Anemia, Hemolytic, Congenital; Antiparkinson Agents; Baclofen; Basal Ganglia; Bas | 2004 |
Effects of gabaergic drugs on reserpine-induced oral dyskinesia.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Baclofen; Behavior, Animal; Diazepam; Dose-Resp | 2005 |
Effects of baclofen on reserpine-induced vacuous chewing movements in mice.
Topics: Adrenergic Uptake Inhibitors; Animals; Baclofen; Brain; Brain Chemistry; Dose-Response Relationship, | 2006 |
Potential aripiprazole-mediated extrapyramidal symptoms in an adult with developmental disabilities.
Topics: Adult; Algorithms; Antipsychotic Agents; Aripiprazole; Baclofen; Basal Ganglia Diseases; Citalopram; | 2007 |
Neuroleptic-induced acute dyskinesias in squirrel monkeys: correlation with propensity to cause extrapyramidal side effects.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Baclofen; Basal Ganglia Diseases; Clozapine; Diaz | 1980 |
[Therapeutic measures in tardive dyskinesia].
Topics: Age Factors; Amantadine; Antipsychotic Agents; Baclofen; Benzodiazepines; Bromocriptine; Deanol; Dih | 1983 |
Phenylethylamine-like properties of baclofen.
Topics: Adult; Aged; Baclofen; Chronic Disease; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; | 1983 |
Effect of sodium valproate and baclofen in tardive dyskinesia: clinical and neuroendocrine studies.
Topics: Adult; Baclofen; Chronic Disease; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Halop | 1980 |
Mania associated with the use of baclofen.
Topics: Adult; Affective Disorders, Psychotic; Baclofen; Bipolar Disorder; Dyskinesia, Drug-Induced; Humans; | 1982 |
Effect of baclofen and haloperidol on gamma-aminobutyric acid and dopamine systems in an animal model of tardive dyskinesia.
Topics: Animals; Baclofen; Brain Chemistry; Disease Models, Animal; Dopamine; Drug Interactions; Dyskinesia, | 1982 |
[Tardive dyskinesia caused by metoclopramide therapy].
Topics: Aged; Baclofen; Dyskinesia, Drug-Induced; Female; Humans; Metoclopramide | 1981 |
Baclofen and tardive dyskinesia.
Topics: Baclofen; Dyskinesia, Drug-Induced; Humans; Male; Middle Aged | 1980 |
Effect of nondopaminergic drugs on L-dopa-induced dyskinesias in MPTP-treated monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Atropine; Baclofen; Clonidine; Dopamine Agent | 1993 |
Baclofen-induced dyskinesia.
Topics: Aged; Baclofen; Dyskinesia, Drug-Induced; Humans; Male | 1993 |
Risks of electronic publishing.
Topics: Baclofen; Dyskinesia, Drug-Induced; Dystonia; Humans; Injections, Spinal; Publishing; Word Processin | 1997 |
Tardive dyskinesia.
Topics: Antipsychotic Agents; Baclofen; Benzodiazepines; Choline; Dyskinesia, Drug-Induced; Humans; Pimozide | 1979 |
[Tardive dyskinesia. Synthetic-critical review and case contribution].
Topics: Adult; Aged; Baclofen; Dyskinesia, Drug-Induced; Female; Humans; Iatrogenic Disease; Male; Mental Di | 1977 |
Treatment-resistant tardive dyskinesia: a new therapeutic approach.
Topics: Aminobutyrates; Baclofen; Deanol; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ethanolamines | 1979 |
The relationship between parkinsonism and tardive dyskinesia.
Topics: Age Factors; Aminobutyrates; Baclofen; Basal Ganglia; Biperiden; Choline; Dopamine; Dyskinesia, Drug | 1977 |
Tardive dystonia: four case histories.
Topics: Adult; Antipsychotic Agents; Baclofen; Benzodiazepines; Bipolar Disorder; Dyskinesia, Drug-Induced; | 1990 |
Neuroleptic-induced "painful legs and moving toes" syndrome: successful treatment with clonazepam and baclofen.
Topics: Baclofen; Causalgia; Clonazepam; Dyskinesia, Drug-Induced; Female; gamma-Aminobutyric Acid; Humans; | 1990 |
Prevalence of tardive dystonia.
Topics: Adult; Aged; Antipsychotic Agents; Baclofen; Cross-Sectional Studies; Dementia; Drug Therapy, Combin | 1986 |
Orofacial dyskinesia induced by baclofen in a patient with hypothyroidism.
Topics: Baclofen; Dyskinesia, Drug-Induced; Facial Paralysis; Female; Humans; Hypothyroidism; Middle Aged | 1986 |